General Info

Founded in 1996, Neuralstem is a publicly traded, biotherapeutics company. It conducts research on stem cells. The company uses the Neural Stem Cell technology to develop treatment options for the diseases of central nervous system. It also uses the Neural Stem Cell technology for the production of mature human neurons. Neuralstem develops a range of treatment options for ischemic paraplegia and Parkinson s disease, as well as several spinal cord injuries.